Document is current
Any future updates will be listed below
-
Authors
Wunderlich, Whitney https://orcid.org/0000-0001-7343-3614
Schulte, Anna https://orcid.org/0000-0002-3382-9822
Schleiss, Mark R. https://orcid.org/0000-0002-2108-9433
Vacquier, Marc https://orcid.org/0000-0002-9248-1547
Sidebottom, Abbey https://orcid.org/0000-0002-5852-3539
-
Funding
Funding for this research was provided by:
Allina Health Foundation
Center for Financial Security Retirement and Disability Research Center (6U19DD001218)
- License Information
-
More Information
Article History
Received: 31 May 2024
Revised: 22 July 2024
Accepted: 2 August 2024
First Online: 13 August 2024
Declarations
:
: The Allina Health Institutional Review Board (IRB, 989271) approved this study.
: MRS is site PI for Moderna mRNA 1647 CMV vaccine trial which provides clinical research support for the UMN, but no personal honoraria or consulting fees are received by the PI. The other authors have no conflicts of interest to report.
